Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer
- 1 December 2009
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 93 (3) , 402-407
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Stereotactic single‐dose radiotherapy (radiosurgery) of early stage nonsmall‐cell lung cancer (NSCLC)Cancer, 2007
- Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastasesRadiation Oncology, 2006
- Clinical outcomes of single‐fraction stereotactic radiation therapy of lung tumorsCancer, 2006
- Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countriesActa Oncologica, 2006
- Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frameInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Stereotactic body radiation therapy of early-stage non–small-cell lung carcinoma: Phase I studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- The role of radiotherapy in treatment of stage I non-small cell lung cancerLung Cancer, 2003
- A Systematic Overview of Radiation Therapy Effects in Non-Small Cell Lung CancerActa Oncologica, 2003
- Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinomaCancer, 1998
- Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patientsActa Oncologica, 1995